(Q69915821)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2895483%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

title

Remoxipride, a selective dopamine D2 receptor antagonist, in tardive dyskinesia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2895483%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

author name string

U Andersson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2895483%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

J E Häggström

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2895483%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

M I Nilsson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2895483%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

E Widerlöv

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2895483%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

publication date

1 January 1988

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2895483%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2895483%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

volume

94

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2895483%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2895483%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

page(s)

167-171

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2895483%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00176839

6 October 2019

exact match

0 references

cites work

Effects of intravenous metoclopramide in 81 patients with tardive dyskinesia

1 reference

12 December 2020

Antipsychotic effect of remoxipride, a new substituted benzamide with selective antidopaminergic activity

1 reference

12 December 2020

Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis.

1 reference

12 December 2020

An open study of remoxipride, a benzamide derivative, in schizophrenia.

1 reference

12 December 2020

Effects of tiapride in tardive dyskinesia

1 reference

12 December 2020

Tardive dyskinesia treated with pimozide

1 reference

12 December 2020

An early phase II clinical trial of remoxipride in schizophrenia with measurement of plasma neuroleptic activity

1 reference

12 December 2020

Potential neuroleptic agents. 2. Synthesis and dopamine blocking activity of some new 2,6-dimethoxybenzamide derivatives

1 reference

12 December 2020

Tiapride in tardive dyskinesia

1 reference

12 December 2020

Tiapride: effects on tardive dyskinesia and on prolactin plasma concentrations

1 reference

12 December 2020

A behavioural and biochemical comparison of dopamine receptor blockade produced by haloperidol with that produced by substituted benzamide drugs

1 reference

12 December 2020

Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain

1 reference

12 December 2020

Tardive dyskinesia: a 3-year follow-up study

1 reference

12 December 2020

Dopaminergic hypersensitivity and cholinergic hypofunction in the pathophysiology of tardive dyskinesia

1 reference

12 December 2020

Treatment of tardive dyskinesia. II. Short-term efficacy of dopamine-blocking agents haloperidol and thiopropazate.

1 reference

12 December 2020

Application of a primate model for tardive dyskinesia

1 reference

12 December 2020

Tolerability and therapeutic effect of clozapine. A retrospective investigation of 216 patients treated with clozapine for up to 12 years

1 reference

12 December 2020

Effect of different neuroleptics in tardive dyskinesia and parkinsonism. A video-controlled multicenter study with chlorprothixene, perphenazine, haloperidol and haloperidol + biperiden. Nordic Dyskinesia Study Group

1 reference

12 December 2020

1 reference

12 December 2020

Therapeutic strategies against tardive dyskinesia. Two decades of experience

1 reference

12 December 2020

A double blind trial of sulpiride in Huntington's disease and tardive dyskinesia

1 reference

12 December 2020

Metoclopramide Treatment of Tardive Dyskinesia

1 reference

12 December 2020

Extrapyramidal side-effects of metoclopramide

1 reference

12 December 2020

Clozapine in tardive dyskinesia

1 reference

12 December 2020

Tiapride in the treatment of tardive dyskinesia

1 reference

12 December 2020

Metoclopramide in Parkinson's disease

1 reference

12 December 2020

Adverse neurologic effects of metoclopramide

1 reference

12 December 2020

Neuroleptic antagonism of dyskinetic phenomena

1 reference

12 December 2020

Tardive dyskinesia during and following treatment with haloperidol, haloperidol + biperiden, thioridazine, and clozapine

1 reference

12 December 2020

The pharmacology of tardive dyskinesias

1 reference

12 December 2020

An open multicentre study of the treatment of florid schizophrenia with remoxipride.

1 reference

12 December 2020

Tardive dyskinesia associated with metoclopramide

1 reference

12 December 2020

Dystonic reactions in children caused by metoclopramide

1 reference

12 December 2020

Research Diagnoses for Tardive Dyskinesia

1 reference

12 December 2020

A rating scale for extrapyramidal side effects

1 reference

12 December 2020

Pharmacological characterization of tardive dyskinesia

1 reference

12 December 2020

Reduction of nigral glutamic acid decarboxylase in rats with neuroleptic-induced oral dyskinesia.

1 reference

12 December 2020